In this episode, Lance Alstodt, CEO of BioRestorative Therapies, talks about their innovative stem cell therapies targeting chronic pain and metabolic disorders. They discuss the company's technology, clinical trials, market potential, and future plans, providing insights into regenerative medicine and biotech investment strategies.BioRestorative Therapies - https://biorestorative.com/Nano Cap Pod Website - https://www.nanocappod.com/DISCLAIMER - The contents of this podcast are for informational purposes only and do not constitute financial, investment, legal, or other professional advice. Listeners should not construe any information discussed as a recommendation to buy, sell, or hold any securities or investments. Always consult with a qualified financial advisor or professional before making any financial decisions.

In this insightful interview, Alex McDougall, CEO of FUTR Corp, explores the intersection of AI, blockchain, and data sovereignty. Discover how their innovative platform acts on your behalf, protects your data, and rewards you for sharing information, revolutionizing personal data management and AI utility.FUTR Corp Website - https://thefutrcorp.com/Nano Cap Podcast Website - https://www.nanocappod.com/DISCLAIMER - The contents of this podcast are for informational purposes only and do not constitute financial, investment, legal, or other professional advice. Listeners should not construe any information discussed as a recommendation to buy, sell, or hold any securities or investments. Always consult with a qualified financial advisor or professional before making any financial decisions.

This week, I speak with Chris Burns, CEO of Amplia Therapeutics, a biotech company developing a promising FAK inhibitor for cancer treatment. Discover the science behind their approach, recent progress in clinical trials, and the vision for transforming pancreatic cancer outcomes.Key Topics:The science behind FAK inhibitors and their role in modulating tumor microenvironmentsHow Amplia's Narmaphonib improves efficacy, durability, and tolerability of pancreatic cancer treatmentsStrategic focus on FDA approval pathway and ongoing clinical trials in the US and AustraliaThe significance of combination therapies in overcoming resistance and enhancing effectivenessThe future potential of FAK inhibitors in treating other solid tumors like ovarian and lung cancerChris Burns' journey from academic research in Australia to biotech leadership and innovationAmplia Therapeutics Website: https://ampliatx.com/Nano Cap Podcast Website https://www.nanocappod.com/DISCLAIMER - The contents of this podcast are for informational purposes only and do not constitute financial, investment, legal, or other professional advice. Listeners should not construe any information discussed as a recommendation to buy, sell, or hold any securities or investments. Always consult with a qualified financial advisor or professional before making any financial decisions.

This week I interview Ed Gillespie, CEO of Abundia Global Impact Group. He shares insights into transforming waste plastics into renewable fuels, the journey of going public, and the vision for scalable green tech solutions. This episode reveals how industry challenges and opportunities align to create a sustainable future.Main Topics Covered:Ed Gillespie’s background and entrepreneurial journey from Ireland to the USThe genesis and growth of Abundia Global Impact GroupThe waste-to-value technology: pyrolysis and upgradation to biofuelsStrategic decisions behind going public and capital deploymentThe significance of siting in Baytown, Texas, and industry culture differencesMarket potential for converting plastic waste into jet fuel and other productsFuture expansion plans: multiple facilities and global market considerationsRole of government support and industry mandates in promoting recycling techThe importance of technological validation and scaling in green tech venturesAbundia's Website - https://abundiaimpact.com/Nano Cap Podcast - https://www.nanocappod.com/DISCLAIMER - The contents of this podcast are for informational purposes only and do not constitute financial, investment, legal, or other professional advice. Listeners should not construe any information discussed as a recommendation to buy, sell, or hold any securities or investments. Always consult with a qualified financial advisor or professional before making any financial decisions.

In this conversation, Bill Wentworth, CEO of Data I/O, shares his extensive background in the tech industry, detailing his journey from working in electronics distribution to leading Data I/O through significant industry changes. He discusses the impact of AI on the tech landscape, the importance of leveraging institutional knowledge, and his vision for the future of Data I/O, emphasizing growth through diversification and innovation.Data IO Website: https://www.dataio.com/Nano Cap Podcast Website: https://www.nanocappod.com/DISCLAIMER - The contents of this podcast are for informational purposes only and do not constitute financial, investment, legal, or other professional advice. Listeners should not construe any information discussed as a recommendation to buy, sell, or hold any securities or investments. Always consult with a qualified financial advisor or professional before making any financial decisions.

In this episode, Will Tjernlund Interviews Jan Goetgeluk the CEO and founder of Virtuix. Jan talks about how he turned a mechanical engineering background into a groundbreaking VR product. From prototypes to NASDAQ listing, learn the story behind the Omni omnidirectional treadmill transforming gaming, training, and defense sectors.In this episode:The origin story of Virtuix and the inception of the Omni treadmillHow VR technology evolved from Palmer Lucky and Oculus influencesThe mechanical design principles behind a compact, affordable omnidirectional treadmillThe role of AI in enabling rapid virtual environment reconstructionVertuix’s dual-use strategy targeting both consumer gaming and defense marketsThe health benefits and fitness impact of VR treadmill gamingFuture plans: international expansion and new application marketsTimestamps:00:00 - Introduction to Jan Goetgeluk and Vertuix's innovative VR treadmill01:14 - Jan’s journey from Belgium to US entrepreneurship01:39 - Deciding to stay in the US and move from banking to startups02:09 - How a mechanical engineering degree fueled a VR mechanical solution02:50 - The significance of Oculus and Palmer Lucky’s early influence03:14 - Why walking naturally in VR was the missing piece in current tech03:54 - Developing the first prototype after hours and the Kickstarter journey04:34 - The breakthrough with the second prototype and viral video of Skyrim in VR05:22 - Reaching out to VC and community support for funding06:20 - The impact of Oculus Kickstarter success on Vertuix’s campaign06:58 - What is the Omni treadmill and its core features07:47 - Growth, recent product launches, and company milestones08:03 - Overcoming mechanical design challenges for smooth and natural walking08:40 - Protecting the mechanical IP with patents and innovations09:31 - How environment mapping and AI enable quick virtual world creation10:04 - Applying VR in defense for terrain familiarization and training11:28 - The dual-use strategy combining gaming with defense contracts12:38 - Balancing consumer scaling with defense applications13:45 - Exploring large B2B opportunities like entertainment centers and theme parks15:12 - Price points aligned with high-end gaming setups16:16 - The health benefits and calorie-burning advantages, with real user examples17:25 - Future plans: international expansion and new markets17:50 - Potential licensing and patent protections19:03 - Jan’s motivation and vision for the next decade19:47 - How to learn more and connect with VertuixResources & Links:Virtuix Official WebsiteNASADAQ Ticker VTIXNano Cap Podcast WebsiteDISCLAIMER - The contents of this podcast are for informational purposes only and do not constitute financial, investment, legal, or other professional advice. Listeners should not construe any information discussed as a recommendation to buy, sell, or hold any securities or investments. Always consult with a qualified financial advisor or professional before making any financial decisions.

In this week's episode, Dr. Lynn Kirkpatrick, CEO of Encyse Biosciences, discusses her journey from academia to entrepreneurship, focusing on innovative solutions for opioid delivery. She highlights the unique approach of her company in developing a safer opioid alternative, the challenges faced in the pharmaceutical industry, and her vision for improving pain management for patients.Ensysce Biosciences Website: https://ensysce.com/Nano Cap Podcast Website: https://www.nanocappod.com/DISCLAIMER - The contents of this podcast are for informational purposes only and do not constitute financial, investment, legal, or other professional advice. Listeners should not construe any information discussed as a recommendation to buy, sell, or hold any securities or investments. Always consult with a qualified financial advisor or professional before making any financial decisions.

In this episode, Will Tjernlund interviews Greg Feller, the president and co-founder of Orion Digital Corp, a financial technology company focused on creating intelligent financial systems. Greg shares insights from his entrepreneurial journey, starting from his college days with his brother, where they first explored business ideas. He discusses his early career on Wall Street, including experiences at Lehman Brothers and Goldman Sachs during pivotal moments in financial history, such as the dot-com boom and the global financial crisis. Greg emphasizes the importance of learning from these experiences and how they shaped the vision for Orion Digital. Greg elaborates on Orion Digital's mission to provide a unique wealth management platform that prioritizes long-term investment strategies over the quick gains often promoted by other trading apps. He highlights the company's innovative approach to intelligent investing, which is designed to help users make informed financial decisions while avoiding the pitfalls of impulsive trading. The conversation also touches on the company's expansion into payment processing and the potential of stablecoins, showcasing Greg's forward-thinking perspective on the evolving financial landscape.Orion Digital Website https://www.orion-digital.com/Nano Cap Podcast Website https://www.nanocappod.com/DISCLAIMER - The contents of this podcast are for informational purposes only and do not constitute financial, investment, legal, or other professional advice. Listeners should not construe any information discussed as a recommendation to buy, sell, or hold any securities or investments. Always consult with a qualified financial advisor or professional before making any financial decisions.

In this episode, Jay Jackson, CEO of Abacus Global Management, discusses the evolution of life insurance as an investment vehicle, the importance of treating life insurance as personal property, and the role of data and technology in predicting mortality. He emphasizes the significance of AI in transforming the insurance industry and shares insights on balancing innovation with revenue generation. The discussion highlights the value of lifespan and the purpose behind their business in providing financial solutions.Abacus Global Management Website: https://abacusgm.com/Nano Cap Podcast Website: https://www.nanocappod.com/DISCLAIMER - The contents of this podcast are for informational purposes only and do not constitute financial, investment, legal, or other professional advice. Listeners should not construe any information discussed as a recommendation to buy, sell, or hold any securities or investments. Always consult with a qualified financial advisor or professional before making any financial decisions.

In this conversation, Vin Singh, CEO of Bullfrog AI, discusses his journey from founding Maxite to leading Bullfrog AI, a company focused on using AI for drug discovery. He shares insights on the challenges in drug development, the importance of proprietary data, and the company's partnerships that have led to significant discoveries in neuropsychiatric disorders. Vin emphasizes the mission of saving lives through technology and outlines the go-to-market strategy for Bullfrog AI.BullfrogAI website: https://bullfrogai.com/Nano Cap Pod Website: https://www.nanocappod.com/DISCLAIMER - The contents of this podcast are for informational purposes only and do not constitute financial, investment, legal, or other professional advice. Listeners should not construe any information discussed as a recommendation to buy, sell, or hold any securities or investments. Always consult with a qualified financial advisor or professional before making any financial decisions.